MEDICINE DETAILS
Alunbrig
Active ingredient: Brigatinib
Neutral reference profile for an independent medicine-access consultancy enquiry about Alunbrig (Brigatinib). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
RECORDED PRODUCT PROFILE
Alunbrig identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
30 mg · 28 tablets Catalogue organisation: TAKEDA GmbH
-
90 mg · 28 tablets Catalogue organisation: TAKEDA GmbH
-
90 mg (7 tablets) + 180 mg (21 tablets) · Treatment initiation pack Catalogue organisation: TAKEDA GmbH
-
180 mg · 28 tablets Catalogue organisation: TAKEDA GmbH
OFFICIAL SOURCES
Check the Alunbrig record at an official source.
Search for “Alunbrig” or “Brigatinib”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Alunbrig.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Alunbrig
01What is Alunbrig?＋
This directory record associates the brand name Alunbrig with the active ingredient Brigatinib. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Alunbrig strengths and packs are recorded?＋
The catalogue currently shows: 30 mg · 28 tablets; 90 mg · 28 tablets; 90 mg (7 tablets) + 180 mg (21 tablets) · Treatment initiation pack; 180 mg · 28 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Alunbrig?＋
Catalogue records currently name: TAKEDA GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Alunbrig?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Alunbrig, payment request, stock guarantee or binding offer.
06Can I buy Alunbrig from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.